Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Patients with Severe Sickle Cell Disease (SCD)

Matthew M Hsieh, Courtney D Fitzhugh, MD, R. Patrick Weitzel, PhD, Wynona Coles, M Beth Link, John F. Tisdale

Blood (2011) 118 (21): 10.

https://doi.org/10.1182/blood.V118.21.10.10

Published: 2011

Journal Articles

Results of Alternative Donor Search in Adult Patients with Severe Sickle Cell Disease (SCD) Eligible for Hematopoietic Stem Cell Transplantation (HSCT).

Matthew M. Hsieh, MD, Jennifer Wilder, Courtney Fitzhugh, MD, Beth Link, RN, John F. Tisdale, MD

Blood (2007) 110 (11): 2260.

https://doi.org/10.1182/blood.V110.11.2260.2260

Published: 2007

Journal Articles

Improvement in Hemolytic Parameters and Tricuspid Regurgitant Jet Velocity (TRV) Following Non-Myeloablative Allogeneic Stem Cell Transplantation (allo-SCT) in Adults with Severe Sickle Cell Disease (SCD).

Matthew M. Hsieh, MD, Beth Link, Roberto Machado, MD, Gregory Kato, MD, Mark Gladwin, MD, John F. Tisdale, MD

Blood (2007) 110 (11): 843.

https://doi.org/10.1182/blood.V110.11.843.843

Published: 2007

Journal Articles

A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.

Matthew M. Hsieh, MD, Elizabeth M. Kang, MD, Beth Link, Maria Berg, Richard W. Childs, MD, Roger Kurlander, MD, Jonathan Powell, MD PhD, Griffin P. Rodgers, MD, John F. Tisdale, MD

Blood (2006) 108 (11): 2994.

https://doi.org/10.1182/blood.V108.11.2994.2994

Published: 2006

Journal Articles

Benign Ethnic Neutropenia in Individuals of African Descent: Incidence, Granulocyte Mobilization, and Gene Expression Profiling.

Matthew Hsieh, Kay Chin, Beth Link, David Stroncek, Ena Wang, James Everhart, John F. Tisdale, Griffin Rodgers

Blood (2005) 106 (11): 3069.

https://doi.org/10.1182/blood.V106.11.3069.3069

Published: 2005

Journal Articles

A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.

Elizabeth M. Kang, MD, Matthew Hsieh, MD, Jonathan D. Powell, MD/PhD, Beth Link, RN, Theresa Donohue, PA, Gregory Kato, MD, Robert Machado, MD, Mark Gladwin, MD, Griffin Rodgers, MD, John F. Tisdale, MD

Blood (2005) 106 (11): 5429.

https://doi.org/10.1182/blood.V106.11.5429.5429

Published: 2005

NARROW

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Patients with Severe Sickle Cell Disease (SCD)

Results of Alternative Donor Search in Adult Patients with Severe Sickle Cell Disease (SCD) Eligible for Hematopoietic Stem Cell Transplantation (HSCT).

Improvement in Hemolytic Parameters and Tricuspid Regurgitant Jet Velocity (TRV) Following Non-Myeloablative Allogeneic Stem Cell Transplantation (allo-SCT) in Adults with Severe Sickle Cell Disease (SCD).

A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.

Benign Ethnic Neutropenia in Individuals of African Descent: Incidence, Granulocyte Mobilization, and Gene Expression Profiling.

A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Patients with Severe Sickle Cell Disease (SCD)

Results of Alternative Donor Search in Adult Patients with Severe Sickle Cell Disease (SCD) Eligible for Hematopoietic Stem Cell Transplantation (HSCT).

Improvement in Hemolytic Parameters and Tricuspid Regurgitant Jet Velocity (TRV) Following Non-Myeloablative Allogeneic Stem Cell Transplantation (allo-SCT) in Adults with Severe Sickle Cell Disease (SCD).

A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.

Benign Ethnic Neutropenia in Individuals of African Descent: Incidence, Granulocyte Mobilization, and Gene Expression Profiling.

A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only